Faculdade de Motricidade Humana
Oeiras, Cruz-Quebrada, 1409-002, Portugal
NCT Number: NCT03823898
The Exercise and Obesity Health Promotion (PESO) program is a randomized controlled trial designed to analyze the effects of a lifestyle intervention in weight management and health-related parameters of overweight and obese premenopausal women
Looking for future studies?
Notify Me24 year–50 year
Female
Interventional
Not applicable
Oeiras, Cruz-Quebrada, 1409-002, Portugal
The PESO (Exercise and Obesity Health Promotion Program) is a program of weight control and exercise promotion for overweight and obese premenopausal women, developed by specialists in exercise, nutrition, and psychology, under medical supervision. It is a program that promotes the autonomy of the participants and the permanent modification of their habits and lifestyles, without the use of drugs or any other products, devices, or techniques of "slimming".
Participants in the PESO Program were able to enjoy a regular and multifaceted group program, aiming to increase knowledge about permanent body weight control, increased motivation and practice of physical activity and exercise, and improved habits food and nutrition. Increases in functional mobility, metabolic health, quality of life and the physical and mental well-being of the participants are central priorities of this Program.
The PESO Program was conducted in a university context and was led by teachers and researchers from the Faculty of Human Motors and other national and foreign institutions. The program is not for commercial purposes, it does not entail financial costs for the participants and it is involved in a wide range of scientific research projects, which have been recognized by individuals and external entities as relevant and of interest to the general population and the community in particular.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Two supervised exercise sessions per week from months 4 to 16
Lifestyle intervention from baseline to 4 months
Monthly behavioral sessions consisted of lifestyle interactive sessions will take place monthly and covered and followed contents that were addressed during the first 4 months of the study
Time frame: 0 months
A scale (Seca, Hamburg, Germany) was used to assess body weight
Time frame: 4 months
A scale (Seca, Hamburg, Germany) was used to assess body weight
Time frame: 16 months
A scale (Seca, Hamburg, Germany) was used to assess body weight
Time frame: 22 months
A scale (Seca, Hamburg, Germany) was used to assess body weight
Time frame: 0 months
A scale (Seca, Hamburg, Germany) was used to determine body height
Time frame: 0 months
Dual-energy x-ray absorptiometry (pencil beam mode, QDR-1500 Hologic, United States) was used to assess changes in total and regional fat and fat-free mass.
Time frame: 4 months
Dual-energy x-ray absorptiometry (pencil beam mode, QDR-1500 Hologic, United States) was used to assess changes in total and regional fat and fat-free mass.
Time frame: 16 months
Dual-energy x-ray absorptiometry (pencil beam mode, QDR-1500 Hologic, United States) was used to assess changes in total and regional fat and fat-free mass.
Time frame: 0 months
Using the same scan parameters, contiguous 7-mm-thick cross-sectional images of both legs were obtained between the inferior ischial tuberosity and the superior border of the patella. Total/subcutaneous thigh Adipose tissue was measured by axial computerized tomography (Somaton Plus; Siemens, Germany).
Time frame: 16 months
Using the same scan parameters, contiguous 7-mm-thick cross-sectional images of both legs were obtained between the inferior ischial tuberosity and the superior border of the patella. Total/subcutaneous thigh Adipose tissue was measured by axial computerized tomography (Somaton Plus; Siemens, Germany).
Time frame: 0 months
Using the same scan parameters, contiguous 7-mm-thick cross-sectional images of both legs were obtained between the inferior ischial tuberosity and the superior border of the patella. Muscle tissue was measured by axial computerized tomography (Somaton Plus; Siemens, Germany).
Time frame: 16 months
Using the same scan parameters, contiguous 7-mm-thick cross-sectional images of both legs were obtained between the inferior ischial tuberosity and the superior border of the patella. Muscle tissue was measured by axial computerized tomography (Somaton Plus; Siemens, Germany).
Time frame: 0 months
With the subjects supine and arms extended above their head, a single cross-sectional axial computerized tomography (Somaton Plus; Siemens, Germany) L4-L5 intervertebral space image was acquired to measure abdominal adipose tissue compartments
Time frame: 16 months
With the subjects supine and arms extended above their head, a single cross-sectional axial computerized tomography (Somaton Plus; Siemens, Germany) L4-L5 intervertebral space image was acquired to measure abdominal adipose tissue compartments
Time frame: 0 months
An enzymatic colorimetric method was used to determine triglycerides
Time frame: 16 months
An enzymatic colorimetric method was used to determine triglycerides
Time frame: 0 months
An enzymatic colorimetric method was used to determine uric acid
Time frame: 16 months
An enzymatic colorimetric method was used to determine uric acid
Time frame: 0 months
An enzymatic colorimetric method was used to determine total cholesterol
Time frame: 16 months
An enzymatic colorimetric method was used to determine total cholesterol
Time frame: 0 months
An enzymatic colorimetric method was were used to determine low-density lipoprotein cholesterol
Time frame: 16 months
An enzymatic colorimetric method was were used to determine low-density lipoprotein cholesterol
Time frame: 0 months
An enzymatic colorimetric method was used to determine high-density lipoprotein cholesterol
Time frame: 16 months
An enzymatic colorimetric method was used to determine high-density lipoprotein cholesterol
Time frame: 0 months
A graded exercise testing with gases analysis was used to assess cardio-respiratory changes
Time frame: 16 months
A graded exercise testing with gases analysis was used to assess cardio-respiratory changes
Time frame: 0 months
Bioelectrical impedance spectroscopy (Hydra 4200 Xitron, United States) was used to assess total-body water
Time frame: 16 months
Bioelectrical impedance spectroscopy (Hydra 4200 Xitron, United States) was used to assess total-body water
Time frame: 0 months
Bioelectrical impedance spectroscopy (Hydra 4200 Xitron, United States) was used to assess extracellular water
Time frame: 16 months
Bioelectrical impedance spectroscopy (Hydra 4200 Xitron, United States) was used to assess extracellular water
Time frame: 0 months
Bioelectrical impedance spectroscopy (Hydra 4200 Xitron, United States) was used to assess intracellular water
Time frame: 16 months
Bioelectrical impedance spectroscopy (Hydra 4200 Xitron, United States) was used to assess intracellular water
Time frame: 0 months
Bioelectrical impedance spectroscopy (Hydra 4200 Xitron, United States) was used to assess resistance
Time frame: 16 months
Bioelectrical impedance spectroscopy (Hydra 4200 Xitron, United States) was used to assess resistance
Time frame: 0 months
Bioelectrical impedance spectroscopy (Hydra 4200 Xitron, United States) was used to assess reactance
Time frame: 16 months
Bioelectrical impedance spectroscopy (Hydra 4200 Xitron, United States) was used to assess reactance
Time frame: 0 months
Bioelectrical impedance spectroscopy (Hydra 4200 Xitron, United States) was used to assess phase angle
Time frame: 16 months
Bioelectrical impedance spectroscopy (Hydra 4200 Xitron, United States) was used to assess phase angle
Time frame: 0 months
Bioelectrical impedance spectroscopy (Hydra 4200 Xitron, United States) was used to assess changes in Bioelectrical Impedance Vector Analysis
Time frame: 16 months
Bioelectrical impedance spectroscopy (Hydra 4200 Xitron, United States) was used to assess changes in Bioelectrical Impedance Vector Analysis
Time frame: 0 months
The quality of life was reported through the SF-36 questionnaire. The SF-36 is a 36-item, generic quality-of-life measure that assesses 8 domains: (1) physical functioning; (2) role limitation due to physical-health problems; (3) bodily pain; (4) general health perceptions; (5) vitality; (6) social functioning; (7) role limitations due to emotional-health problems; and (8) mental health. Social function, vitality, and general health perceptions scales measure both physical and mental health status. All health measures were scored on scales of 0 to 100, with higher scores indicating better health.
Time frame: 4 months
The quality of life was reported through the SF-36 questionnaire. The SF-36 is a 36-item, generic quality-of-life measure that assesses 8 domains: (1) physical functioning; (2) role limitation due to physical-health problems; (3) bodily pain; (4) general health perceptions; (5) vitality; (6) social functioning; (7) role limitations due to emotional-health problems; and (8) mental health. Social function, vitality, and general health perceptions scales measure both physical and mental health status. All health measures were scored on scales of 0 to 100, with higher scores indicating better health.
Time frame: 16 months
The quality of life was reported through the SF-36 questionnaire. The SF-36 is a 36-item, generic quality-of-life measure that assesses 8 domains: (1) physical functioning; (2) role limitation due to physical-health problems; (3) bodily pain; (4) general health perceptions; (5) vitality; (6) social functioning; (7) role limitations due to emotional-health problems; and (8) mental health. Social function, vitality, and general health perceptions scales measure both physical and mental health status. All health measures were scored on scales of 0 to 100, with higher scores indicating better health.
Time frame: 0 months
A sphygmomanometer was used to determine changes in systolic and diastolic blood pressure
Time frame: 16 months
A sphygmomanometer was used to determine changes in systolic and diastolic blood pressure
Time frame: 0 months
A self-reported measure of physical activity was used, specifically the short-form of the International physical activity questionnaire (IPAQ-SF). The IPAQ-SF records the last 7 day recall for four intensity levels of physical activity which is vigorous-intensity activity, moderate-intensity activity, walking, and sitting. From IPAQ data were converted to Metabolic Equivalent minutes per week (MET-min/week) using the published formulation the Compendium average MET score. Physical activity of low intensity was characterized by activities inducing less than 3 metabolic equivalents (MET), moderate intensity between 3 and 5.9 MET and for vigorous intensity higher than 6 MET. The higher the number of MET, the higher the intensity. The duration of the activities in each intensity were calculated based on the reported time per week. The higher the duration in activities of moderate to vigorous physical activity the highest the physical activity level
Time frame: 4 months
A self-reported measure of physical activity was used, specifically the short-form of the International physical activity questionnaire (IPAQ-SF). The IPAQ-SF records the last 7 day recall for four intensity levels of physical activity which is vigorous-intensity activity, moderate-intensity activity, walking, and sitting. From IPAQ data were converted to Metabolic Equivalent minutes per week (MET-min/week) using the published formulation the Compendium average MET score. Physical activity of low intensity was characterized by activities inducing less than 3 metabolic equivalents (MET), moderate intensity between 3 and 5.9 MET and for vigorous intensity higher than 6 MET. The higher the number of MET, the higher the intensity. The duration of the activities in each intensity were calculated based on the reported time per week. The higher the duration in activities of moderate to vigorous physical activity the highest the physical activity level
Time frame: 16 months
A self-reported measure of physical activity was used, specifically the short-form of the International physical activity questionnaire (IPAQ-SF). The IPAQ-SF records the last 7 day recall for four intensity levels of physical activity which is vigorous-intensity activity, moderate-intensity activity, walking, and sitting. From IPAQ data were converted to Metabolic Equivalent minutes per week (MET-min/week) using the published formulation the Compendium average MET score. Physical activity of low intensity was characterized by activities inducing less than 3 metabolic equivalents (MET), moderate intensity between 3 and 5.9 MET and for vigorous intensity higher than 6 MET. The higher the number of MET, the higher the intensity. The duration of the activities in each intensity were calculated based on the reported time per week. The higher the duration in activities of moderate to vigorous physical activity the highest the physical activity level
Time frame: 0 months
Energy intake was assessed during a 3-day period by a 24-hour diet record. Subjects were instructed regarding portion sizes, supplements, food preparation aspects, and other aspects pertaining to an accurate recording of their energy intake. Records were turned in and reviewed at the time of laboratory testing for total energy intake. Dietary records were analyzed using a software package (Food Processor SQL, ESHA Research, Salem, OR, USA).
Time frame: 4 months
Energy intake was assessed during a 3-day period by a 24-hour diet record. Subjects were instructed regarding portion sizes, supplements, food preparation aspects, and other aspects pertaining to an accurate recording of their energy intake. Records were turned in and reviewed at the time of laboratory testing for total energy intake. Dietary records were analyzed using a software package (Food Processor SQL, ESHA Research, Salem, OR, USA).
Time frame: 16 months
Energy intake was assessed during a 3-day period by a 24-hour diet record. Subjects were instructed regarding portion sizes, supplements, food preparation aspects, and other aspects pertaining to an accurate recording of their energy intake. Records were turned in and reviewed at the time of laboratory testing for total energy intake. Dietary records were analyzed using a software package (Food Processor SQL, ESHA Research, Salem, OR, USA).
Time frame: 0 months
Macro-nutrient intake was assessed during a 3-day period by a 24-hour diet record. Subjects were instructed regarding portion sizes, supplements, food preparation aspects, and other aspects pertaining to an accurate recording of their food intake. Records were turned in and reviewed at the time of laboratory testing. Dietary records were analyzed using a software package (Food Processor SQL, ESHA Research, Salem, OR, USA).
Time frame: 4 months
Macro-nutrient intake was assessed during a 3-day period by a 24-hour diet record. Subjects were instructed regarding portion sizes, supplements, food preparation aspects, and other aspects pertaining to an accurate recording of their food intake. Records were turned in and reviewed at the time of laboratory testing. Dietary records were analyzed using a software package (Food Processor SQL, ESHA Research, Salem, OR, USA).
Time frame: 16 months
Macro-nutrient intake was assessed during a 3-day period by a 24-hour diet record. Subjects were instructed regarding portion sizes, supplements, food preparation aspects, and other aspects pertaining to an accurate recording of their food intake. Records were turned in and reviewed at the time of laboratory testing. Dietary records were analyzed using a software package (Food Processor SQL, ESHA Research, Salem, OR, USA).
Time frame: 0 months
Micronutrient intake was assessed during a 3-day period by a 24-hour diet record. Subjects were instructed regarding portion sizes, supplements, food preparation aspects, and other aspects pertaining to an accurate recording of their food intake. Records were turned in and reviewed at the time of laboratory testing. Dietary records were analyzed using a software package (Food Processor SQL, ESHA Research, Salem, OR, USA).
Time frame: 4 months
Micronutrient intake was assessed during a 3-day period by a 24-hour diet record. Subjects were instructed regarding portion sizes, supplements, food preparation aspects, and other aspects pertaining to an accurate recording of their food intake. Records were turned in and reviewed at the time of laboratory testing. Dietary records were analyzed using a software package (Food Processor SQL, ESHA Research, Salem, OR, USA).
Time frame: 16 months
Micronutrient intake was assessed during a 3-day period by a 24-hour diet record. Subjects were instructed regarding portion sizes, supplements, food preparation aspects, and other aspects pertaining to an accurate recording of their food intake. Records were turned in and reviewed at the time of laboratory testing. Dietary records were analyzed using a software package (Food Processor SQL, ESHA Research, Salem, OR, USA).
Time frame: 0 months
Indirect calorimetry for determining resting metabolic rate
Time frame: 16 months
Indirect calorimetry for determining resting metabolic rate
Time frame: 0 months
An anthropometric tape was used to measure body circumferences
Time frame: 4 months
An anthropometric tape was used to measure body circumferences
Time frame: 16 months
An anthropometric tape was used to measure body circumferences
Time frame: 0 months
A caliper was used to measure skinfolds
Time frame: 4 months
A caliper was used to measure skinfolds
Time frame: 16 months
A caliper was used to measure skinfolds
Time frame: 0 months
Electrochemiluminescence immunoassay (ECLIA) was used to assess fasting insulin
Time frame: 16 months
Electrochemiluminescence immunoassay (ECLIA) was used to assess fasting insulin
Time frame: 0 months
Fasting glycemia was assessed by hexokinase method
Time frame: 16 months
Fasting glycemia was assessed by hexokinase method
Time frame: 0 months
Interleukin-6 (IL-6) was measured by chemiluminescence immunoassay
Time frame: 16 months
Interleukin-6 (IL-6) was measured by chemiluminescence immunoassay
Time frame: 0 months
Tumor necrosis factor-alpha (TNF-alpha) was measured using a high-sensitivity enzyme linked immunosorbent assay (ELISA) principle
Time frame: 16 months
Tumor necrosis factor-alpha (TNF-alpha) was measured using a high-sensitivity enzyme linked immunosorbent assay (ELISA) principle
Time frame: 0 months
Plasminogen activator inhibitor-1 (PAI-1) was measured in iced citrated plasma using the Coatest PAI method (enzyme immunoassay-EIA)
Time frame: 16 months
Plasminogen activator inhibitor-1 (PAI-1) was measured in iced citrated plasma using the Coatest PAI method (enzyme immunoassay-EIA)
Time frame: 0 months
Fibrinogen concentrations were measured by clotting time
Time frame: 16 months
Fibrinogen concentrations were measured by clotting time
Time frame: 0 months
Hemoglobin A1c (Hb A1c) was determined by high-pressure liquid chromatography (HPLC)
Time frame: 16 months
Hemoglobin A1c (Hb A1c) was determined by high-pressure liquid chromatography (HPLC)
Time frame: 0 months
Serum adiponectin concentration was measured by radioimmunoassay (RIA)
Time frame: 16 months
Serum adiponectin concentration was measured by radioimmunoassay (RIA)
Time frame: 0 months
Serum leptin concentration was measured by radioimmunoassay (RIA)
Time frame: 16 months
Serum leptin concentration was measured by radioimmunoassay (RIA)
Time frame: 0 months
Urine cortisol was measured by radioimmunoassay (RIA)
Time frame: 16 months
Urine cortisol was measured by radioimmunoassay (RIA)
Time frame: 0 months
Microalbuminuria plasma concentration was measured by high-sensitivity particle-enhanced turbidimetric assay
Time frame: 16 months
Microalbuminuria plasma concentration was measured by high-sensitivity particle-enhanced turbidimetric assay
Time frame: 0 months
C-reactive protein plasma concentration was measured by high-sensitivity particle-enhanced turbidimetric assay
Time frame: 16 months
C-reactive protein plasma concentration was measured by high-sensitivity particle-enhanced turbidimetric assay
Time frame: 0 months
Apolipoprotein A1 plasma concentration was measured by high-sensitivity particle-enhanced turbidimetric assay
Time frame: 16 months
Apolipoprotein A1 plasma concentration was measured by high-sensitivity particle-enhanced turbidimetric assay
Time frame: 0 months
Apolipoprotein B100 plasma concentration was measured by high-sensitivity particle-enhanced turbidimetric assay
Time frame: 16 months
Apolipoprotein B100 plasma concentration was measured by high-sensitivity particle-enhanced turbidimetric assay
Time frame: 0 months
Alanine aminotransferase was determined by a kinetic method
Time frame: 16 months
Alanine aminotransferase was determined by a kinetic method
Time frame: 0 months
Aspartate aminotransferase was determined by a kinetic method
Time frame: 16 months
Aspartate aminotransferase was determined by a kinetic method
Faculdade de Motricidade Humana
Other
Lifestyle Intervention in Overweight and Obese Premenopausal Women
Acronym: PESO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05056376
Behavior, Body Weight
Baltimore, Maryland, United States
View Trial DetailsNCT05249465
Behavior, Body Weight
Stanford, California, United States
View Trial DetailsNCT05394779
Behavior, Behavior, Animal
Milan, Italy
View Trial DetailsNCT01818674
Behavior, Behavior, Health
Amman, Jordan
View Trial Details